Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/184457
Title: | Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study |
Author: | Pérez González, Alexandre Araújo Ameijeiras, Alejandro Fernández Villar, Alberto Crespo, Manuel Poveda, Eva Cabrera, Jorge Julio Campo, Víctor del Gil de Araujo, Beatriz Gómez, Carlos Leiro, Virginia Longueira, María Rebeca López Domínguez, Ana Ramón Lorenzo, José Marcos, María Pérez, María Teresa Patiño, Lucia Pérez, Sonia Pérez Fernández, Silvia Ramos, Cristina Regueiro, Benito Retresas, Cristina Rivera, Tania Souto, Olga Taboada, Isabel Teijeira, Susana Torres, María Val, Vanesa Viéitez, Irene Cohort Covid-19 Of The Galicia Sur Health Research Institute |
Keywords: | COVID-19 Malalts crònics COVID-19 Chronically ill |
Issue Date: | 1-Mar-2022 |
Publisher: | Springer Science and Business Media LLC |
Abstract: | Survivors to COVID-19 have described long-term symptoms after acute disease. These signs constitute a heterogeneous group named long COVID or persistent COVID. The aim of this study is to describe persisting symptoms 6 months after COVID-19 diagnosis in a prospective cohort in the Northwest Spain. This is a prospective cohort study performed in the COHVID-GS. This cohort includes patients in clinical follow-up in a health area of 569,534 inhabitants after SARS-CoV-2/COVID-19 diagnosis. Clinical and epidemiological characteristics were collected during the follow up. A total of 248 patients completed 6 months follow-up, 176 (69.4%) required hospitalization and 29 (10.2%) of them needed critical care. At 6 months, 119 (48.0%) patients described one or more persisting symptoms. The most prevalent were: extra-thoracic symptoms (39.1%), chest symptoms (27%), dyspnoea (20.6%), and fatigue (16.1%). These symptoms were more common in hospitalized patients (52.3% vs. 38.2%) and in women (59.0% vs. 40.5%). The multivariate analysis identified COPD, women gender and tobacco consumption as risk factors for long COVID. Persisting symptoms are common after COVID-19 especially in hospitalized patients compared to outpatients (52.3% vs. 38.2%). Based on these findings, special attention and clinical follow-up after acute SARS-CoV-2 infection should be provided for hospitalized patients with previous lung diseases, tobacco consumption, and women. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41598-022-07414-x |
It is part of: | Scientific Reports, 2022, vol 12, num 1 |
URI: | http://hdl.handle.net/2445/184457 |
Related resource: | https://doi.org/10.1038/s41598-022-07414-x |
ISSN: | 2045-2322 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s41598-022-07414-x.pdf | 1.05 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License